Symbiomix Therapeutics - Ownership and Business Overview

Life ScienceCompany

Symbiomix Therapeutics Ownership

Who owns Symbiomix Therapeutics?

Symbiomix Therapeutics is owned by Eight Roads and Lupin. It was acquired on October 11, 2017.

Is Symbiomix Therapeutics PE-backed?

Yes. Symbiomix Therapeutics is owned by private equity investors Eight Roads and Lupin.

Symbiomix Therapeutics Business Overview

Where is Symbiomix Therapeutics headquartered?

Symbiomix Therapeutics is headquartered in Newark, New Jersey.

What sector is Symbiomix Therapeutics in?

Symbiomix Therapeutics is a life science company.

When was Symbiomix Therapeutics founded?

Symbiomix Therapeutics was founded in 2012.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Symbiomix Therapeutics

Symbiomix Therapeutics LLC

105 Lock Street, Suite 409,
Newark, New Jersey 07103
United States,
(609) 722-7250
www.symbiomix.com

Symbiomix Therapeutics is a privately held company focused on bringing innovative therapies to market for gynecologic infections that can have serious health consequences. Symbiomix Therapeutics was founded in 2012 and is based in Newark, New Jersey.


Company Summary

SECTOR

Life Science

Established

2012

 Subscribe to unlock this and 202,135
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Symbiomix Therapeutics

New Jersey Companies , Life Science Companies , United States Companies , New Jersey Life Science Companies , New Jersey Life Science with Acquisitions , New Jersey Life Science with Divestitures

Related Lists for New Jersey Companies

Largest New Jersey Companies , Acquisitive New Jersey Companies , Recently Acquired New Jersey Companies , Recently Sold New Jersey Companies , Private New Jersey Companies , Public New Jersey Companies , Acquired New Jersey Companies , PE Backed New Jersey Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal